SUCAMPO PHARMACEUTICALS, INC. Decrease in Restricted Cash
SUCAMPO PHARMACEUTICALS, INC. reported Decrease in Restricted Cash of $12.30 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Notes
us-gaap:DecreaseInRestrictedCash · last filed 2016-11-09
- SUCAMPO PHARMACEUTICALS, INC. decrease in restricted cash for the quarter ending 2016-09-30 was $1.70M.
- SUCAMPO PHARMACEUTICALS, INC. decrease in restricted cash for the quarter ending 2016-06-30 was $0.00.
- SUCAMPO PHARMACEUTICALS, INC. decrease in restricted cash for the quarter ending 2016-03-31 was $10.60M.
| Period end | Decrease in Restricted Cash 3 month | Decrease in Restricted Cash 6 month | Decrease in Restricted Cash 9 month |
|---|---|---|---|
| 2016-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.70M derived: sum of 2 quarters · filed 2016-11-09 | $12.30M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $10.60M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $10.60M 10-Q · filed 2016-05-05 | ||
| 2015-09-30 | $548.00K 10-Q · filed 2016-11-09 |